Purkinje cell toxicity of beta-aminopropionitrile in the rat
- PMID: 1750186
- DOI: 10.1007/BF01605074
Purkinje cell toxicity of beta-aminopropionitrile in the rat
Abstract
Compounds causing neurolathyrism are putative aetiological agents in neurodegenerative disorders including amyotrophic lateral sclerosis. beta-Aminopropionitrile (BAPN) is one such compound. We have administered this lathyrogenic agent at a dose of 1 g/kg by the intraperitoneal route in experiments in adult Sprague-Dawley rats during a period of 10 weeks. The rats developed marked kyphoscoliosis, ataxia with paralysis and muscle wasting of the hind limbs. Vacuolation and loss of Purkinje cells developed, but no anterior horn cell degeneration was noted. Immunohistochemical studies of phosphorylated neurofilaments and the 72 kDa heat shock protein were normal and no intraneuronal ubiquitinated inclusions were seen. High-dose intraperitoneal BAPN in the rat causes Purkinje cell changes, but no other central nervous system abnormalities.
Similar articles
-
The alkylating agent penclomedine induces degeneration of purkinje cells in the rat cerebellum.Invest New Drugs. 2003 Aug;21(3):269-79. doi: 10.1023/a:1025456224751. Invest New Drugs. 2003. PMID: 14578677
-
The immunosuppressant FK506 elicits a neuronal heat shock response and protects against acrylamide neuropathy.Exp Neurol. 2004 May;187(1):160-70. doi: 10.1016/j.expneurol.2004.01.005. Exp Neurol. 2004. PMID: 15081597
-
Ethanol-induced alterations of neurotrophin receptor expression on Purkinje cells in the neonatal rat cerebellum.Brain Res. 2002 Jan 4;924(1):71-81. doi: 10.1016/s0006-8993(01)03224-3. Brain Res. 2002. PMID: 11743997
-
Appearance of lamellar structures in the Purkinje cells of rat cerebellum after administration of beta-aminopropionitrile.Experientia. 1974 Sep 15;30(9):1030-2. doi: 10.1007/BF01938991. Experientia. 1974. PMID: 4412069 No abstract available.
-
GDNF and IGF-I trophic factors delay hereditary Purkinje cell degeneration and the progression of gait ataxia.Exp Neurol. 2003 Sep;183(1):205-19. doi: 10.1016/s0014-4886(03)00172-9. Exp Neurol. 2003. PMID: 12957504
Cited by
-
Anti-fibrotic, muscle-promoting antibody-drug conjugates for the improvement and treatment of DMD.iScience. 2025 Apr 2;28(5):112335. doi: 10.1016/j.isci.2025.112335. eCollection 2025 May 16. iScience. 2025. PMID: 40276765 Free PMC article.
-
The rationale for targeting the LOX family in cancer.Nat Rev Cancer. 2012 Jul 19;12(8):540-52. doi: 10.1038/nrc3319. Nat Rev Cancer. 2012. PMID: 22810810 Review.
-
Critical involvement of lysyl oxidase in seizure-induced neuronal damage through ERK-Alox5-dependent ferroptosis and its therapeutic implications.Acta Pharm Sin B. 2022 Sep;12(9):3513-3528. doi: 10.1016/j.apsb.2022.04.017. Epub 2022 May 10. Acta Pharm Sin B. 2022. PMID: 36176900 Free PMC article.
-
Simulated microgravity-induced aortic remodeling.J Appl Physiol (1985). 2009 Jun;106(6):2002-8. doi: 10.1152/japplphysiol.90777.2008. Epub 2009 Mar 19. J Appl Physiol (1985). 2009. PMID: 19299573 Free PMC article.